Immunologic Predisposition of HIV Patients to Develop Methicillin-Resistant Staphylococcus Aureus (MRSA) Colonization and Infection
MRSA-2
1 other identifier
observational
52
1 country
2
Brief Summary
The purpose of this study is to investigate the role of T helper 17 cells (Th17) in the pathogenesis of MRSA infections.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Mar 2009
Longer than P75 for all trials
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2009
CompletedFirst Submitted
Initial submission to the registry
March 10, 2009
CompletedFirst Posted
Study publicly available on registry
March 11, 2009
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2010
CompletedStudy Completion
Last participant's last visit for all outcomes
August 26, 2016
CompletedFebruary 15, 2023
February 1, 2023
1.7 years
March 10, 2009
February 13, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
To compare distribution of Th17 cells and their functionality, in the peripheral blood of HIV-positive patients who are infected with MRSA with that of HIV-positive patients who are not colonized or infected with Staphylococcus aureus.
1 year
Secondary Outcomes (4)
Compare distribution of Th17 cells in the peripheral blood of groups of HIV-positive and HIV-negative participants who are colonized with MRSA as well as those who have a MRSA infection.
1 year
Examine distribution of T cells, B cells, macrophages, dendritic cells, neutrophils, defensins, and IL-17 in T cell subsets in the skin
1 year
Compare Th17 cells in peripheral blood of HIV-negative participants with MRSA infection with that of HIV-negative subjects not colonized of infected with Staph aureus.
1 year
Collect information on factors that may play a role in development of MRSA colonization/infection. Includes demographic, hygienic, exercise-related, and sexual factors which may contribute to MRSA.
1 year
Study Arms (6)
1
HIV-positive and MRSA negative
2
HIV-positive and MRSA infected (skin/soft tissue)
3
HIV-positive and MRSA colonized
4
HIV-negative and MRSA negative
5
HIV-negative and MRSA infected (skin/soft tissue)
6
HIV-negative and MRSA colonized
Eligibility Criteria
HIV-positive and negative patients with a recent screen for MRSA colonization or a history of MRSA infection will be asked to participate. Participants will be recruited by providers within the infectious disease clinics at the sites. In addtion, MRSA isolates will be monitored at the central laboratory and providers of patients with MRSA will be notified and asked to notify their patients of the opportunity to participate in this study.
You may qualify if:
- Greater or equal to 18 years of age
- Willingness to undergo blood draw. Skin biopsy will be requested, but is optional
- AND-
- HIV-positive and MRSA-negative Group:
- Documented positive HIV test result
- Negative colonization swabs for S. aureus within 14 days of enrollment
- No evidence of skin/soft tissue infection
- HIV-positive and MRSA-Colonization Group:
- Documented positive HIV test result
- History of of colonization with MRSA w/in 14 days of study enrollment
- HIV-positive and MRSA Infection Group:
- Documented positive HIV test result
- Skin/soft tissue infection with a positive wound culture showing MRSA within 7 days of enrollment
- MRSA infection is not associated with an intravenous catheter or other nosocomial procedure
- HIV Negative groups:
- +3 more criteria
You may not qualify if:
- Women with positive urine pregnancy test within 7 days of study enrollment
- Women who are within 6 months of being postpartum or who are currently breastfeeding
- Subjects unable or unwilling to complete questionnaires and blood draw.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
Naval Medical Center San Diego
San Diego, California, 92134, United States
Walter Reed National Military Medical Center
Bethesda, Maryland, 20889, United States
Related Publications (1)
Utay NS, Roque A, Timmer JK, Morcock DR, DeLeage C, Somasunderam A, Weintrob AC, Agan BK, Estes JD, Crum-Cianflone NF, Douek DC. MRSA Infections in HIV-Infected People Are Associated with Decreased MRSA-Specific Th1 Immunity. PLoS Pathog. 2016 Apr 19;12(4):e1005580. doi: 10.1371/journal.ppat.1005580. eCollection 2016 Apr.
PMID: 27093273RESULT
Biospecimen
Skin biopsy will be obtained.
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 10, 2009
First Posted
March 11, 2009
Study Start
March 1, 2009
Primary Completion
November 1, 2010
Study Completion
August 26, 2016
Last Updated
February 15, 2023
Record last verified: 2023-02